{"id":"W4380084899","doi":"10.1002/hon.3164_420","title":"Final safety and efficacy results of copanlisib monotherapy in patients with relapsed or refractory iNHL: 6‐year follow‐up of CHRONOS‐1","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Gilead Sciences; Eisai; Sanofi; Servier; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Adverse effect; Rituximab; Follicular lymphoma; Clinical endpoint; Phases of clinical research; Lymphoma; Refractory (planetary science); Gastroenterology; Surgery; Oncology; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002277639,0.0001514468,0.0008885954,0.0001307852,0.00002397733,0.000001910647,0.00006603517,0.0002325238,0.00007656794],"category_scores_gemma":[0.0003581723,0.00008584401,0.00006048588,0.0003286037,0.0002186459,0.00002850253,0.00005083752,0.0001181588,0.00001404329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001403529,"about_ca_system_score_gemma":0.0001920923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004635374,"about_ca_topic_score_gemma":0.00005641372,"domain_scores_codex":[0.9985507,0.000112652,0.0005930052,0.0003045685,0.0002066676,0.0002324408],"domain_scores_gemma":[0.9984481,0.0009111238,0.0002434473,0.0002225908,0.00008098648,0.00009370605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09973941,0.004966651,0.8743674,0.000127639,0.0001787027,0.0005358043,0.0005980664,0.000007357823,0.00008375962,0.0007009893,0.00207974,0.01661444],"study_design_scores_gemma":[0.07337371,0.01433592,0.906653,0.0001687641,0.00005459785,0.00002233704,0.00008869358,0.00001387247,0.0005529391,0.00002991788,0.004619287,0.00008687597],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974395,0.0001039571,0.000002403022,0.0007663761,0.00006022693,0.0005819802,0.00003194127,0.00003417601,0.000979414],"genre_scores_gemma":[0.9987307,0.0003628874,0.0005177771,0.0001193359,0.00001039897,0.00003078438,0.00007516728,0.00001159818,0.0001413648],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03228563,"threshold_uncertainty_score":0.3500617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03957222822548243,"score_gpt":0.3165948374563731,"score_spread":0.2770226092308906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}